Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Giovanni F M Strippoli
Metformin as First-Line Treatment for Type 2 Diabetes
The Lancet
Medicine
Related publications
Metformin Remains the Best Treatment for Type 2 Diabetes
BMJ
Cost-Effectiveness of First-Line Versus Delayed Use of Combination Dapagliflozin and Metformin in Patients With Type 2 Diabetes
Scientific Reports
Multidisciplinary
Use of Metformin and Vildagliptin for Treatment of Type 2 Diabetes in the Elderly
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Should Sodium Glucose Co-Transporter 2 Inhibitors Be Considered as First Line Oral Therapy for People With Type 2 Diabetes?
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Intensive Insulin Therapy as the Primary Treatment for Type 2 Diabetes
Clinical Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Cost-Effectiveness Analysis of Linagliptin Versus Sulfonylurea as Add-On Treatment to Metformin for the Treatment of Diabetes Mellitus Type 2 Patients in Indonesia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Exploring Treatment Strategies for Type 2 Diabetes
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Metformin in Patients With Type 2 Diabetes and Kidney Disease
JAMA - Journal of the American Medical Association
Medicine
